HIRSCHMAN ORIN 13D and 13G filings for Hepion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-28 4:57 pm Sale |
2020-12-23 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
HIRSCHMAN ORIN | 1,173 4.000% |
-827 (-41.34%) |
Filing |
| 2020-12-09 06:49 am Purchase |
2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
HIRSCHMAN ORIN | 2,000 6.900% |
2,000 (New Position) |
Filing |